Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain

被引:9
作者
Panizzutti, Bruna [1 ]
Bortolasci, Chiara C. [1 ]
Spolding, Briana [1 ]
Kidnapillai, Srisaiyini [1 ]
Connor, Timothy [1 ]
Richardson, Mark F. [2 ]
Truong, Trang T. T. [1 ]
Liu, Zoe S. J. [1 ]
Gray, Laura [1 ,3 ]
Kim, Jee Hyun [1 ,3 ]
Dean, Olivia M. [1 ,3 ]
Berk, Michael [1 ,3 ,4 ,5 ]
Walder, Ken [1 ,6 ]
机构
[1] Deakin Univ, Sch Med, Inst Innovat Phys & Mental Hlth & Clin Translat, IMPACT, Geelong, Vic 3220, Australia
[2] Deakin Univ, Sch Life & Environm Sci, Genom Ctr, Geelong, Vic 3220, Australia
[3] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Psychiat, Parkville, Vic 3052, Australia
[5] Univ Melbourne, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia
[6] Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
antipsychotics; weight gain; schizophrenia; lipid metabolism; bipolar disorder; metabolic syndrome; psychiatry; neuroscience; mental disorders; GENE POLYMORPHISMS; METABOLIC SYNDROME; SCHIZOPHRENIA; EXPRESSION;
D O I
10.3390/jcm10184095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Weight gain and consequent metabolic alterations are common side-effects of many antipsychotic drugs. Interestingly, several studies have suggested that improvement in symptoms and adverse metabolic effects are correlated. We used next generation sequencing data from NT-2 (human neuronal) cells treated with aripiprazole, amisulpride, risperidone, quetiapine, clozapine, or vehicle control, and compared with the Pillinger P-score (ranked from 0 to 1, indicating greater increase in weight gain and related metabolic parameters) to identify the genes most associated with the drugs' propensity to cause weight gain. The top 500 genes ranked for their correlation with the drugs' propensity to cause weight gain were subjected to pathway analysis using DAVID (NIH). We further investigated transcription factors (TFs) that are more likely to regulate the genes involved in these processes using the prediction tool of key TFs from TRRUST. The results suggest an enrichment for genes involved in lipid biosynthesis and metabolism, which are of interest for mechanisms underpinning weight-gain. The list of genes involved in the lipid pathways that correlated with weight gain was enriched for genes transcriptionally regulated by SREBF1 and SREBF2. Furthermore, quetiapine significantly increased the expression of SREBF1 and SREBF2 in NT-2 cells. Our results suggest that the effects of these antipsychotic drugs on lipid metabolism may be mediated, at least in part, via regulation of SREBF1/SREBF2 expression, with evidence of a direct effect of quetiapine on the expression of SREBF1/2. The effects of antipsychotic drugs on lipid metabolism may influence white matter structure (therapeutic effect) and the risk of weight gain, lipid disturbances, and, consequently, metabolic syndrome (adverse effects). Understanding the different molecular effects of these drugs could inform a personalized medicine approach in treating patients with schizophrenia.
引用
收藏
页数:8
相关论文
共 41 条
  • [11] Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
    Correll, Christoph U.
    Solmi, Marco
    Veronese, Nicola
    Bortolato, Beatrice
    Rosson, Stella
    Santonastaso, Paolo
    Thapa-Chhetri, Nita
    Fornaro, Michele
    Gallicchio, Davide
    Collantoni, Enrico
    Pigato, Giorgio
    Favaro, Angela
    Monaco, Francesco
    Kohler, Cristiano
    Vancampfort, Davy
    Ward, Philip B.
    Gaughran, Fiona
    Carvalho, Andre F.
    Stubbs, Brendon
    [J]. WORLD PSYCHIATRY, 2017, 16 (02) : 163 - 180
  • [12] Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
    De Hert, M.
    Dobbelaere, M.
    Sheridan, E. M.
    Cohen, D.
    Correll, C. U.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26 (03) : 144 - 158
  • [13] Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
    Ferno, J
    Raeder, MB
    Vik-Mo, AO
    Skrede, S
    Glambek, M
    Tronstad, KJ
    Breilid, H
    Lovlie, R
    Berge, RK
    Stansberg, C
    Steen, VM
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (05) : 298 - 304
  • [14] Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines:: Marked differences between various antipsychotic drugs
    Ferno, Johan
    Skrede, Silje
    Vik-Mo, Audun O.
    Havik, Bjarte
    Steen, Vidar M.
    [J]. BMC NEUROSCIENCE, 2006, 7 (1)
  • [15] Lipogenic effects of psychotropic drugs: focus on the SREBP system
    Ferno, Johan
    Skrede, Silje
    Vik-Mo, Audun Osland
    Jassim, Goran
    Le Hellard, Stephanie
    Steen, Vidar Martin
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 49 - 60
  • [16] Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia
    Garver, David L.
    Holcomb, Jennifer A.
    Christensen, James D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (01) : 49 - 61
  • [17] Altered reward anticipation: Potential explanation for weight gain in schizophrenia?
    Grimm, Oliver
    Kaiser, Stefan
    Plichta, Michael M.
    Tobler, Philippe N.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 75 : 91 - 103
  • [18] TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
    Han, Heonjong
    Cho, Jae-Won
    Lee, Sangyoung
    Yun, Ayoung
    Kim, Hyojin
    Bae, Dasom
    Yang, Sunmo
    Kim, Chan Yeong
    Lee, Muyoung
    Kim, Eunbeen
    Lee, Sungho
    Kang, Byunghee
    Jeong, Dabin
    Kim, Yaeji
    Jeon, Hyeon-Nae
    Jung, Haein
    Nam, Sunhwee
    Chung, Michael
    Kim, Jong-Hoon
    Lee, Insuk
    [J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) : D380 - D386
  • [19] Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
    Huang, Da Wei
    Sherman, Brad T.
    Lempicki, Richard A.
    [J]. NATURE PROTOCOLS, 2009, 4 (01) : 44 - 57
  • [20] The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
    Kidnapillai, Srisaiyini
    Bortolasci, Chiara C.
    Udawela, Madhara
    Panizzutti, Bruna
    Spolding, Briana
    Connor, Timothy
    Sanigorski, Andrew
    Dean, Olivia M.
    Crowley, Tamsyn
    Jamain, Stephane
    Gray, Laura
    Scarr, Elizabeth
    Leboyer, Marion
    Dean, Brian
    Berk, Michael
    Walder, Ken
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (10) : 775 - 783